Muse细胞球对小鼠和树鼩角膜瘢痕创伤有治疗作用
研究从脂肪抽吸物分离多能样Muse细胞,经静态球体培养33天扩增约100倍并维持表型与高活力;动态旋转细胞培养系统(RCCS)激活后干性、活性与贴附增强,可分化为角膜基质细胞(CSCs)。将Muse来源CSCs负载于两层正交堆叠拉伸压缩胶原(cell-SCC)植入小鼠和树鼩损伤角膜,可阻止角膜瘢痕形成、促进再上皮化与神经再生、减轻炎症和新生血管,且经长距离冻存运输后仍保留抑制瘢痕能力。
要点
- Muse细胞可从脂肪抽吸物分离,静态球体培养33天扩增约100倍并保持高活力。
- RCCS激活的Muse球体干性标志物与增殖标志物表达高于静态组。
- cell-SCC植入小鼠和树鼩角膜可减少瘢痕、炎症与新生血管并促神经再生。
核心结论
- Muse细胞球经RCCS激活后可分化为角膜基质细胞,负载于cell-SCC植入动物角膜可抑制瘢痕形成并改善愈合。
- Muse细胞疗法是治疗角膜瘢痕的有前景方向。
研究设计与样本
- 基础与转化研究:从脂肪抽吸物分离Muse细胞,静态球体培养扩增并表征。
- 采用动态旋转细胞培养系统(RCCS)激活Muse球体并与静态组比较。
- 在小鼠和树鼩角膜损伤模型中植入Muse-CSCs负载的cell-SCC观察疗效。
主要发现
- Muse细胞同时呈现多能干细胞和部分间充质干细胞的双表型特征。
- 静态球体培养33天扩增约100倍,维持Muse表型和高细胞活力。
- RCCS组OCT3/4、SOX2、NANOG和KI67的基因与蛋白表达高于静态组。
- Muse-CSCs表达角膜基质细胞特征标志基因和蛋白。
- cell-SCC植入小鼠和树鼩角膜可阻止瘢痕形成、增加再上皮化和神经再生、减轻炎症和新生血管。
临床怎么用
- Muse细胞可经脂肪抽吸物获取并球体扩增,具备规模化制备潜力。
- RCCS激活可提升Muse球体干性与贴附,利于后续分化与移植。
- cell-SCC可经长距离冻存运输后仍保留抑制角膜瘢痕的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stem cell therapy holds promises for treating corneal scarring. Here, we use multilineage-differentiating stress-enduring (Muse) cells to study their differentiation and therapeutic potential for treating corneal injury. Muse cells were isolated from lipoaspirate, which presented biphenotype properties of both pluripotent stem cells and some mesenchymal stem cells. Muse cells expanded by about 100-fold from the initial seeding cell number to Muse spheroids with the maintenance of the Muse cell phenotype and high cell viability at 33 days by static spheroid culture. We revealed that Muse spheroids were activated by the dynamic rotary cell culture system (RCCS), as characterized by increased stemness, improved activity, and enhanced adherence. Gene and protein expression of the pluripotent markers OCT3/4, SOX2, and NANOG and of the proliferation marker KI67 in Muse spheroids cultured under RCCS were higher than those in the static group. These activated Muse spheroids enabled ready differentiation into corneal stromal cells (CSCs) expressing characteristic marker genes and proteins. Furthermore, implantation of Muse cells-differentiated CSCs (Muse-CSCs) laden assembled with two orthogonally stacked stretched compressed collagen (cell-SCC) in mouse and tree shrew wounded corneas prevented the formation of corneal scarring, increased corneal re-epithelialization and nerve regrowth, and reduced the severity of corneal inflammation and neovascularization. cell-SCC retained the capacity to suppress corneal scarring after long-distance cryopreserved transport. Thus, Muse cell therapy is a promising avenue for developing therapeutics for treating corneal scarring.
引用
- Guo Y, Xue Y, Wang P, et al. Muse cell spheroids have therapeutic effect on corneal scarring wound in mice and tree shrews. Sci Transl Med. 2020. PMID: 32967971. doi:10.1126/scitranslmed.aaw1120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。